Home > Healthcare > Pharmaceuticals > Finished Drug Form > Abortion Drugs Market

Abortion Drugs Market Share

Report ID: GMI8059
Published Date: Feb 2024
Report Format: PDF

Download Free Sample

Abortion Drugs Market Share

These leading players are actively engaging in the production and distribution of abortion drugs and competing to meet the growing demand to widen their customer base and global presence. They are continuing to innovate and expand their offerings by adapting to evolving healthcare needs and regulatory changes. Partnership strategies and R&D initiatives are also employed by these firms to proliferate their portfolio.

Abortion Drugs Market Companies

Major players in the abortion drugs industry include:

Cipla Limited
Endo International plc
Exelgyn
Gedeon Richter plc
Jubilant Life Sciences
Lupin Limited
Mylan N.V.
Pfizer Inc.
Sun Pharmaceutical Industries
Torrent Pharmaceuticals Ltd.
Zydus Lifesciences Limited

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global abortion drugs market size was valued at over USD 24.42 billion in 2023 and is estimated to grow at 8.2% CAGR from 2024-2032, driven by the rising rate of abortions.

The mifepristone segment of the market is poised to record 8.6% CAGR from 2024-2032, propelled by the rising pivotal role of mifepristone in abortion procedures.

North America abortion drugs market size recorded decent growth in 2023 and is predicted to witness 8.4% CAGR through 2032, owing to the presence of an improved healthcare infrastructure.

Cipla Limited, Endo International plc, Exelgyn, Gedeon Richter plc, Jubilant Life Sciences, Lupin Limited, and Mylan N.V. among others.